Tokai Investor Marks Underwriters Liable In $10.8M Suit
A Tokai Pharmaceuticals Inc. investor is fighting to keep alive a $10.8 million suit alleging that the company failed to disclose that too few research subjects were left to yield meaningful...To view the full article, register now.
Already a subscriber? Click here to view full article